CCL20 and breast carcinoma: In addition, ELAVL1 expression showed a strong positive correlation with CCL20 expression (Fig. 3b) but not with CSF2 (Supplementary Fig. 5b) or CCR6 expression (Supplementary Fig. 5c) in breast cancer subtypes, particularly the basal-like subtype.